Caldan Therapeutics

UK-based, preclinical-stage biopharma developing therapeutics targeting free fatty acid receptors for Type 2 Diabetes & NASH

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2015 groups3 employees language caldantherapeutics.com

Registered entities

Investor mix

10 investors on record; lead investors include Epidarex Capital.

Investor typeCountShare
Venture capital330%
Other / undisclosed770%
Coming soon